[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mimedx Group Inc (MDXG)

Mimedx Group Inc (MDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 527,269
  • Shares Outstanding, K 148,946
  • Annual Sales, $ 418,630 K
  • Annual Income, $ 48,580 K
  • EBIT $ 40 M
  • EBITDA $ 55 M
  • 60-Month Beta 1.46
  • Price/Sales 1.27
  • Price/Cash Flow 6.43
  • Price/Book 2.18

Options Overview Details

View History
  • Implied Volatility 226.53% (-13.42%)
  • Historical Volatility 64.66%
  • IV Percentile 76%
  • IV Rank 30.81%
  • IV High 683.97% on 03/04/26
  • IV Low 22.85% on 09/04/25
  • Expected Move (DTE 1) 0.86 (24.39%)
  • Put/Call Vol Ratio 6.67
  • Today's Volume 69
  • Volume Avg (30-Day) 105
  • Put/Call OI Ratio 0.80
  • Today's Open Interest 3,689
  • Open Int (30-Day) 3,583
  • Expected Range 2.66 to 4.38

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.03
  • Number of Estimates 1
  • High Estimate $-0.03
  • Low Estimate $-0.03
  • Prior Year $0.10
  • Growth Rate Est. (year over year) -130.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.03 +16.36%
on 04/29/26
4.05 -13.19%
on 04/14/26
-0.40 (-10.20%)
since 04/13/26
3-Month
3.03 +16.36%
on 04/29/26
5.46 -35.53%
on 02/24/26
-1.60 (-31.25%)
since 02/13/26
52-Week
3.03 +16.36%
on 04/29/26
7.99 -55.94%
on 07/31/25
-3.65 (-50.91%)
since 05/13/25

Most Recent Stories

More News
MIMEDX Announces Launch of G4Derm® Plus

Flowable Biomimetic Matrix Adds Self-Assembling Peptide Technology to Company’s Portfolio G4Derm Plus Added to Premier and Vizient GPO Agreements MARIETTA, Ga., May 08, 2026 (GLOBE NEWSWIRE)...

MDXG : 3.52 (-0.56%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG

NEW YORK , May 7, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of MiMedx Group, Inc. ("MiMedx" or the "Company") (NASDAQ: MDXG).  Such investors are advised...

MDXG : 3.52 (-0.56%)
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues

MALVERN, Pa., April 30, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today...

AXGN : 40.29 (-1.56%)
TELA : 0.9600 (-5.88%)
ANIK : 14.80 (+0.82%)
MDXG : 3.52 (-0.56%)
ELUT : 1.0500 (unch)
BVS : 10.40 (+2.56%)
MiMedx: Q1 Earnings Snapshot

MiMedx: Q1 Earnings Snapshot

MDXG : 3.52 (-0.56%)
MIMEDX Announces First Quarter 2026 Operating & Financial Results

Reports  First Quarter Net Sales of $59 Million Revises 2026 Net Sales and Adjusted EBITDA Expectations Management to Host Conference Call Today, April 29, 2026, at 4:30 PM ET ...

MDXG : 3.52 (-0.56%)
MiMedx Reports While Medicare Reimbursement Questions Still Lack Answers

Barchart Research What to Expect from MDXG Earnings MDXG Generated April 28, 2026 Current Price $3.40 EPS Estimate $$-0.07 Consensus Rating Strong Buy Average Move 9.85% MiMedx Reports While Medicare Reimbursement...

MDXG : 3.52 (-0.56%)
MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29

MARIETTA, Ga., April 22, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the...

MDXG : 3.52 (-0.56%)
MIMEDX Announces Restructuring and Cost Reduction Initiative

MARIETTA, Ga., April 16, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced a series of cost reduction initiatives intended to prioritize growth...

MDXG : 3.52 (-0.56%)
MIMEDX to Sponsor Leading Advanced Wound Care Conferences

Multispecialty Focus with Industry Leadership Aimed at Improving Patient Outcomes Company Will Feature Recent Additions to Its Advanced Wound Care Portfolio MARIETTA, Ga., April 02, 2026 (GLOBE...

MDXG : 3.52 (-0.56%)
MIMEDX Announces Launch of CHORIOFIX™

MARIETTA, Ga., March 23, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the commercial launch of CHORIOFIX™, the latest advanced wound...

MDXG : 3.52 (-0.56%)

Business Summary

MiMedx is an integrated developer, processor and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. `Innovations in Regenerative Biomaterials` is the framework behind their mission to give physicians products and tissues to help the...

See More

Key Turning Points

3rd Resistance Point 3.69
2nd Resistance Point 3.63
1st Resistance Point 3.57
Last Price 3.52
1st Support Level 3.46
2nd Support Level 3.40
3rd Support Level 3.34

See More

52-Week High 7.99
Fibonacci 61.8% 6.09
Fibonacci 50% 5.51
Fibonacci 38.2% 4.92
Last Price 3.52
52-Week Low 3.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.